ORPHA:140957
Autosomal dominant macrothrombocytopenia
- Type
- Disease
- Group
- Disorder
- Inheritance
- Autosomal dominant
- Age of onset
- Adolescent, Adult, Childhood, Elderly, Infancy
- Status
- active
A rare isolated constitutional thrombocytopenia characterized by abnormally large platelets.
1
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Autosomal dominant macrothrombocytopenia | |
| fr | Macrothrombocytopénie autosomique dominante | |
| de | Makrothrombozytopenie, autosomal-dominante | |
| es | Macrotrombocitopenia autosómica dominante | |
| it | Macrotrombocitopenia autosomica dominante | |
| nl | Autosomaal dominante macrotrombocytopenie | |
| pt | Macrotrombocitopenia autossómica dominante | |
| pl | Autosomalna dominująca makrotrombocytopenia | |
| cs | Autozomálně dominantní makrotrombocytopenie | |
| uk | Аутосомно-домінантна макротромбоцитопенія | |
| zh | 常染色体显性遗传巨血小板减少症 | |
| tr | Otozomal dominant makrotrombositopeni |
Definition in:
2
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| OMIM | 187800 | NTBT | validated | |
| OMIM | 613112 | BTNT | validated | |
| OMIM | 615193 | BTNT | validated | |
| OMIM | 619271 | BTNT | validated | |
| OMIM | 619840 | BTNT | validated | |
| OMIM | 620486 | BTNT | validated | |
| ICD-10 | D69.1 | NTBT | attributed | validated |
| ICD-11 | 3B62.01 | NTBT | attributed | validated |
| MONDO | 0015372 | E | validated | |
| UMLS | C4304021 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
3
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:220452Isolated hereditary giant platelet disorder
rare genetic diseases; rare hematological diseases
No children.
4
Genes
10 direct| Gene | Association | Status | HGNC | Ensembl | OMIM | Locus | Name | Source of validation |
|---|---|---|---|---|---|---|---|---|
| TPM4 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:12013 | ENSG00000167460 | 600317 | 19p13.12-p13.11 | tropomyosin 4 | 28134622[PMID] |
| ACTN1 | Disease-causing germline mutation(s) in | Assessed | HGNC:163 | ENSG00000072110 | 102575 | 14q24.1 | actinin alpha 1 | 23434115[PMID] |
| GFI1B | Disease-causing germline mutation(s) in | Assessed | HGNC:4238 | ENSG00000165702 | 604383 | 9q34.13 | growth factor independent 1B transcriptional repressor | 23927492[PMID] |
| GP1BA | Disease-causing germline mutation(s) in | Assessed | HGNC:4439 | ENSG00000185245 | 606672 | 17p13.2 | glycoprotein Ib platelet subunit alpha | 21933849[PMID] |
| GP1BB | Disease-causing germline mutation(s) in | Assessed | HGNC:4440 | ENSG00000203618 | 138720 | 22q11.21 | glycoprotein Ib platelet subunit beta | 28064200[PMID] |
| ITGA2B | Disease-causing germline mutation(s) in | Assessed | HGNC:6138 | ENSG00000005961 | 607759 | 17q21.31 | integrin subunit alpha 2b | 21454453[PMID] |
| ITGB3 | Disease-causing germline mutation(s) in | Assessed | HGNC:6156 | ENSG00000259207 | 173470 | 17q21.32 | integrin subunit beta 3 | 18065693[PMID]_19336737[PMID] |
| TRPM7 | Disease-causing germline mutation(s) in | Assessed | HGNC:17994 | ENSG00000092439 | 605692 | 15q21.2 | transient receptor potential cation channel subfamily M member 7 | 27020697[PMID] |
| TUBA8 | Disease-causing germline mutation(s) in | Assessed | HGNC:12410 | ENSG00000183785 | 605742 | 22q11.21 | tubulin alpha 8 | 34704371[PMID] |
| TUBB1 | Disease-causing germline mutation(s) in | Assessed | HGNC:16257 | ENSG00000101162 | 612901 | 20q13.32 | tubulin beta 1 class VI | 18849486[PMID] |
5
Prevalence and incidence
2 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Cases/families | 100 cases | Worldwide | Case(s) | Validated | 18065693[PMID]_18849486[PMID]_24069336[PMID] | |
| Point prevalence | <1 / 1 000 000 | — | Worldwide | Class only | Validated | ORPHANET |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
6
HPO phenotypes
9 annotations · validated 2025-11-20| HPO | Term (as annotated by Orphanet) | Diagnostic |
|---|---|---|
| Very frequent (99-80%) | ||
| HP:0011877 | Increased mean platelet volume | |
| HP:0040185 | Macrothrombocytopenia | |
| HP:0001873 | Thrombocytopenia | |
| Frequent (79-30%) | ||
| HP:0032438 | Platelet anisocytosis | |
| Occasional (29-5%) | ||
| HP:0000978 | Bruising susceptibility | |
| HP:0000421 | Epistaxis | |
| HP:0100608 | Metrorrhagia | |
| HP:0006298 | Prolonged bleeding after dental extraction | |
| HP:0004846 | Prolonged bleeding after surgery | |
Run the differential on the 3 obligate / very frequent terms
Annotation source: 33813986[PMID]_33276370[PMID]
7
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/140957
- This record as JSON: /data/d/140957.json